Brackmann Christoph's Form 4 filing
NovoCure Ltd (NVCR) · filed Jul 30, 2025
- Accession no.
- 0001562180-25-005572
- Filed
- Jul 30, 2025
- Trade date
- Jul 29, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $231.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brackmann ChristophCIK 0002048634 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | Ordinary Shares | PPurchaseAcquired | +10,000 | $11.63 | +$116,300 | 131,150 | Direct | |
| Jul 29, 2025 | Ordinary Shares | PPurchaseAcquired | +5,000 | $11.60 | +$58,000 | 136,150 | Direct | |
| Jul 29, 2025 | Ordinary Shares | PPurchaseAcquired | +5,000 | $11.50 | +$57,500 | 141,150 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.